Investor Alert

New York Markets After Hours

Email Story

Blueprint's stock falls 11% after sharing new Phase 2 data for its rare-disease therapy

By Jaimy Lee, MarketWatch
8/17/2022 09:01:49 AM
** denotes Required Fields

Send this story to: **

Enter the e-mail address of the recipient. Separate multiple addresses with commas.

Add your own personal message:

Enter your e-mail address: **

Note: Your e-mail address, and that of your recipients, will be used only in the case of transmission errors and to let the recipient know who sent the story. The information will not be used for any other purpose.

Format: HTML Text-only

Verification keywords

Partner Center

Link to MarketWatch's Slice.